Resmed beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea. The company makes continuous positive airway pressure (CPAP ...

Medical device company ResMed (NYSE:RMD) in Q2 CY2025, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit ...

Resmed (NYSE: RMD) today reported second-quarter financial results that came in ahead of the consensus Wall Street forecast.

Investing.com-- Australian shares of Resmed (NYSE: RMD) Inc DRC (ASX: RMD) hit a record high on Friday after the medical ...

Industry Prospects Per a report by Grand View Research, the global sleep apnea devices market size was valued at $4.5 billion in 2023 and is expected to grow at a CAGR of 6.2% from 2023 to 2030.

ResMed launches new bi-level sleep apnea device as CPAP alternative By Andrea Park Feb 13, 2024 10:24am ResMed CPAP device sleep apnea medical device ...

ResMed is a global leader in digital health and connected medical devices, focusing on sleep apnea and respiratory care solutions. The company holds approximately 55-62% of the market share in ...

Lastly, Farrell believes the rise of GLPs will have a Botox effect on sleep apnea, as patients become more aware of the disease and doctors use all tools to treat the disease, including ResMed’s ...

ResMed CEO on how wearables, GLP-1s will impact sleep apnea device sales CEO Mick Farrell sees the ‘two tidal waves’ of innovation driving more people to ResMed’s devices Courtesy ResMed/NYSE ...

Local medical device maker ResMed is adjusting its executive leadership assignments and cutting back its workforce to accommodate a shift in strategy. The San Diego-based company is pushing to ...

ResMed beat Wall Street estimates for second-quarter revenue and profit on Wednesday, powered by strong demand for its respiratory devices used to treat sleep apnea. Adjusted profit of $1.88 per ...

Industry Prospects Per a report by Grand View Research, the global sleep apnea devices market size was valued at $4.50 billion in 2023 and is expected to grow at a CAGR of 6.2% by 2030.